Bruce Rathie


Bruce Rathie

Non-Executive Director


Bruce is a highly qualified, professional Non-Executive Company Director with over 17 years’ experience in successful senior executive careers in law and investment banking. He practiced as a legal partner and acted as Senior In-house Counsel to Bell Resources Limited from 1980 to 1985, then received his MBA at the University of Geneva & IMI (now IMD), embarking on an investment banking career in 1986. He was Head of the Industrial Franchise Group at Salomon Smith Barney in the late 1990s and led Salomon’s roles in the Federal Government’s privatization of Qantas, Commonwealth Bank and Telstra.

He brings an expansive skill set to 4Dx that draws upon his experiences in management, finance, law, compliance & regulation, technology and biotechnology, as well as start-up IPO management and technology commercialization.  In the medical device sector, he was previously Chairman of Anteo Diagnostics Limited, and a Director of Compumedics Limited and USCOM Limited.

Bruce’s current roles include Independent Non-Executive Director and Vice-Chairman of Capricorn Society Limited, Independent Non-Executive Director & Chairman of Capricorn Mutual Limited, and Independent Non-Executive Director of Australian Meat Processor Corporation Limited.

Bruce served as Non-Executive director and chair of PolyNovo from 2004 through to February 2010, and continues to serve as an Independent Non-Executive Director of the ASX listed company. PolyNovo is a medical device corporation which develops and manufactures biodegradable polymers.  PolyNovo currently has distribution in Australia, New Zealand and the US with current market capitalization in excess of $1 billion.